Globus Medical GMED Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Globus Medical's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value?
- Globus Medical (GMED) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value of $65.86M in Q1 2026.
- How has Globus Medical's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value changed year-over-year?
- Globus Medical's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value increased by 34.3% year-over-year, from $49.06M to $65.86M.
- What is the long-term trend for Globus Medical's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value?
- Over 4 years (2020 to 2024), Globus Medical's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value has grown at a 4.7% compound annual growth rate (CAGR), from $88.76M to $106.82M.